isoborneol has been researched along with Central Nervous System Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ZX; Huang, YY; Wang, Y; Xu, MB; Zheng, GQ; Zheng, Q; Zhou, XL | 1 |
1 review(s) available for isoborneol and Central Nervous System Disease
| Article | Year |
|---|---|
Borneol, a messenger agent, improves central nervous system drug delivery through enhancing blood-brain barrier permeability: a preclinical systematic review and meta-analysis.
Topics: Animals; Blood-Brain Barrier; Camphanes; Central Nervous System Agents; Central Nervous System Diseases; Drug Carriers; Female; Humans; Male; Permeability | 2018 |